<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-molecules-25-03830">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mahanta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chowdhury</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gogoi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Goswami</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Borah</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Chetia</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Borah</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Buragohain</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Gogoi</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: An 
   <italic>in silico</italic> based approach [published online ahead of print, 25 May 2020]
  </article-title>
  <source>J. Biomol. Struct. Dyn.</source>
  <year>2020</year>
  <fpage>1</fpage>
  <lpage>10</lpage>
  <pub-id pub-id-type="doi">10.1080/07391102.2020.1768902</pub-id>
 </element-citation>
</ref>
